SYNLAB International Overview

  • Founded
  • 1998

Founded
  • Status
  • Public

  • Employees
  • 30,000

Employees
  • Stock Symbol
  • SYAB

Stock Symbol
  • Investments
  • 33

  • Share Price
  • $19.35

  • (As of Monday Closing)

SYNLAB International General Information

Description

Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Contact Information

Website
www.synlab.com
Formerly Known As
Synlab Holding
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
BER
Primary Office
  • Moosacher Straße 88
  • 80809 Munich
  • Germany
+49 089 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SYNLAB International Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.35 $19.56 $14.60 - $27.96 $4.35B 222M 19.03 $3.41

SYNLAB International Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 5,786,766 7,684,550
Revenue 4,515,549 4,451,255 2,987,921 2,350,834
EBITDA 1,437,328 1,413,884 734,058 497,033
Net Income 757,864 738,656 293,595
Total Assets 6,421,473 6,143,367 6,498,148
Total Debt 2,265,053 2,294,807 3,861,550
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SYNLAB International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SYNLAB International‘s full profile, request access.

Request a free trial

SYNLAB International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for pra
Laboratory Services (Healthcare)
Munich, Germany
30,000 As of 2021
00.000
0.000 0000-00-00
00000000 00.000

000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000 00000000 (0000000000)
Saint-Denis, France
00000 As of 0000
00000
000000000 00 00000

000000

odo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000000000 00000000 (0000000000)
Waltham, MA
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SYNLAB International Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biogroup (France) Private Equity-Backed Saint-Denis, France 00000 00000 000000000 00 00000
000000 00000000 00 Corporate Backed or Acquired Waltham, MA 000000&0
000000 000 0 Private Equity-Backed Aix en Provence, France 000 000000000 00
0000 000000000000 Corporation Salt Lake City, UT
0000000 Formerly PE-Backed Geneva, Switzerland 00000 000 000000&0 000
You’re viewing 5 of 7 competitors. Get the full list »

SYNLAB International Patents

SYNLAB International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3353541-A1 Method for dosing volatile short-chain fatty acids Pending 21-Sep-2015 000000000
EP-3137901-A1 Method for dosing urinary organic acids Granted 29-Apr-2014 00000000000
EP-3137901-B1 Method for determining urinary organic acids Active 29-Apr-2014 00000000000 0
US-20150362475-A1 Prediction of kidney disease progression using homoarginine as a biomarker Abandoned 18-Jan-2013 0000000000 0
EP-2946213-A1 Prediction of kidney disease progression using homoarginine as a biomarker Pending 18-Jan-2013 G01N33/487
To view SYNLAB International’s complete patent history, request access »

SYNLAB International Executive Team (21)

Name Title Board Seat Contact Info
Mathieu Floreani Chief Executive Officer
Thomas Degott Chief Executive Officer - Emerging Markets
Sami Badarani Chief Financial Officer & Managing Director
Robert Steinwander Chief Operating Officer
Luis Vieira Chief Strategy Officer
You’re viewing 5 of 21 executive team members. Get the full list »

SYNLAB International Board Members (15)

Name Representing Role Since
0000 000000 Cinven Board Member 000 0000
000000000000 000000 SYNLAB International Board Member 000 0000
000000000 0000000 Self Board Member 000 0000
0000 00000000 SYNLAB International Board Member 000 0000
00000 000000000 SYNLAB International Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

SYNLAB International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SYNLAB International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SYNLAB International‘s full profile, request access.

Request a free trial

SYNLAB International Investments & Acquisitions (33)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000ó 04-Jan-2022 0000000000 000.00 Biotechnology 0000000 0
00000000000 0 02-Nov-2021 0000000000 Laboratory Services (Healthcare)
000000 000000 22-Jul-2021 0000000000 Clinics/Outpatient Services 0000000 0
000000 000000 06-Aug-2019 0000000000 Laboratory Services (Healthcare)
Dansk Medicinsk Data Distribution 01-Jan-2019 Buyout/LBO Outcome Management (Healthcare)
You’re viewing 5 of 33 investments and acquisitions. Get the full list »

SYNLAB International Subsidiaries (13)

Company Name Industry Location Founded
Lextox Other Commercial Services Cardiff, United Kingdom 2011
00000000 00000 000 Laboratory Services (Healthcare) Helsinki, Finland 0000
000000 Biotechnology Budapest, Hungary 0000
0000000000 Laboratory Services (Healthcare) Sapporo, Japan 0000
00000 000000000000 Laboratory Services (Healthcare) Birsfelden, Switzerland 0000
You’re viewing 5 of 13 subsidiaries. Get the full list »

SYNLAB International Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 000000 02-Sep-2016 0000000000 Completed
  • 6 buyers
To view SYNLAB International’s complete exits history, request access »